Biocon Limited (BIOCON) Share Analysis
NSE · Healthcare · Pharmaceuticals
Biocon Limited (NSE: BIOCON) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 200, NIFTY 500, NIFTY Healthcare Index. As of 14 Nov 2026, the share price was ₹364.00, P/E 87.1, ROE 1.4%.
Get the AI verdict on BIOCON: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
BIOCON chart with trendlines
Is BIOCON a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Biocon Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
BIOCON key facts
| Price and valuation | |
|---|---|
| Share price | ₹364.00 |
| Market cap | ₹59,329 Cr |
| P/E ratio | 87.1 |
| P/B ratio | 1.7 |
| EPS | ₹2.98 |
| Book value per share | ₹214.00 |
| Dividend yield | 0.14% |
| 52-week range | |
| 52-week high | ₹447.15 |
| 52-week low | ₹318.40 |
| Face value | ₹5.00 |
| Shareholding pattern | |
| Promoters | 44.68% |
| FIIs | 8.64% |
| DIIs | 29.22% |
| Public | 17.2% |
Index membership: NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 100, NIFTY Midcap 150, NIFTY MidSmallcap 400, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.